Trends in lipid levels and hypercholesterolemia in hypertensive and normotensive Finnish adults from 1982 to 1997

Journal of Internal Medicine

Volumn 247, Issue 1, 2000, Pages 53-62

  Kastarinen, Mika ^a   Tuomilehto, J ^b   Vartiainen, E ^b   Jousilahti, P ^b   Sundvall, J ^b   Puska, P ^b   Nissinen, A ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Awareness; Cross sectional population survey; Hypercholesterolemia; Hypertension

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED;

EID: 0033979849     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00573.x     Document Type: Article

References (35)

1. 1 Zanchetti A. Hyperlipidemia in the hypertensive patient. Am J Med 1994; 96 (Suppl. 4A): 1S-6S.
2. 2 Stamler J, Wentworth D, Neaton JD. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Am J Med 1986; 80 (Suppl. 2A): 33S-6S.
3. 3 Assmann G, Schulte H. The prospective cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart diasease. Am Heart J 1988; 116: 1713-24.
4. 4 Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. JAMA 1987; 258: 1768-76.
5. 5 Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K, together with the members of the Task Force. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998; 16: 1407-14.
6. 6 The Sixth Report of the Joint National Committee on Prevention, Detection Evaluation, Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
7. 7 WHO MONICA Project Principal Investigators. The World Health Organization Monica Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-14.
8. 8 Salomaa V, Tuomilehto J, Kartovaara L et al. Trends in Cardiovascular Risk Factors in Treated and Untreated Hypertensive and Normotensive Finnish Subjects, 1982-1987. Rev Epidemiol Sante Publications 1990; 38:493-500.
9. 9 National Public Health Institute. Monitoring Trends and Determinants of Cardiovascular Diseases in Finland: the MONICA Study. Helsinki: National Public Health Institute, 1982.
10. 10 Kostner GM. Enzymatic determination of cholesterol in high density lipoprotein fraction prepared by polyanion precipitation. Clin Chem 1976; 22: 695-701.
11. 11 Freeman DH Jr The saturated log-linear model. In: Owen DB, Cornell RG, eds. Applied Categorical Data Analysis. New York: Marcel Dekker, Inc., 1987: 210-3.
12. 12 Poulter NR, Zographos D, Mattin R, Sever PS, Thom SmcG. Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practices. Blood Pressure 1996: 5: 209-15.
13. 13 Nilsson P, Andersson DKG, Andersson PE et al. Cardiovascular risk factors in treated hypertensives - a nation-wide, cross-sectional study in Sweden. J Intern Med 1993; 233: 239-45.
14. 14 Macmahon SW, MacDonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 1985; 5: 391-6.
15. 15 Hense HW, Döring A, Stieber J, Keil U. The association of antihypertensive treatment patterns and adverse lipid effects in population-based studies. J Clin Epidemiol 1992; 45: 1423-30.
16. 16 Lochen ML. The Tromso Heart Study: coronary risk factor levels in treated and untreated hypertensives. Acta Med Scand 1988; 224: 515-21.
17. 17 Pietinen P, Vartiainen E, Männistö S. Trends in body mass index and obesity in Finland from 1972 to 1992. Int J Obes 1996; 20: 114-20.
18. 18 Pietinen P, Vartiainen E, Seppänen R, Aro A, Puska P. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med 1996; 25: 243-50.
19. 19 Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in North Karelia and in other areas of Finland. Int J Epidemiol 1994; 23: 495-504.
20. 20 National Agency for Medicines and Social Insurance Institution. Finnish Statistics on Medicines 1997. Helsinki, 1998.
21. 21 Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 1986; 256: 2835-8.
22. 22 Jeppesen J, Facchini FS, Reaven GM. Individuals with high total cholesterol/HDL-cholesterol ratios are insulin resistant. J Intern Med 1998; 243: 293-8.
23. 23 Isles CG, Walker LM, Beevers GD et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986: 4: 141-56.
24. 24 Bulpitt CJ, Beevers GD, Butler A et al. The survival of treated hypertensive patients and their causes of death: a report from the DHSS Hypertensive Care Computing Project (DHCCP). J Hypertens 1986: 4: 93-100.
25. 25 Alexander RW. Theodore Cooper Memorial Lecture: Hypertension and the pathogenesis of atherosclerosis. Hypertension 1995; 25: 155-61.
26. 26 Lehman ED, Hopkins KD, Gosling RG. Relation between aortic atherosclerosis and blood pressure. Lancet 1994; 343: 1106-07.
27. 27 Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension and coronary heart disease. Lancet 1995; 345: 362-4.
28. 28 Kastarinen MJ, Salomaa VV, Vartiainen EA et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertension 1998; 16: 1379-87.
29. 29 Puska P, Iacono JM, Nissinen A et al. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet 1983; 1: 1-5.
30. 30 Nissinen M, Pietinen P, Tuomilehto J, Vartiainen E, Iacono JM, Puska P. Predictors of blood pressure change in series of controlled dietary intervention studies. J Hum Hypertens 1987; 1: 167-73.
31. 31 Fagerberg B, Wikstrand J, Berglund G, Samuelsson O, Agewall S. for the Risk Factor Intervention Study Group. Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced. Am J Hypertens 1998; 11: 14-22.
32. 32 Hasnain S, Webster J, McLay JS. Cardiovascular risk in hypertension: implications of the Sheffield Table for lipid-lowering strategy. J Hum Hypertens 1998; 12: 469-71.
33. 33 Unwin N, Thomson R, O'Byrne AM, Laker M, Amstrong H. Implications of applying widely accepted cholesterol screening and management guidelines to British adult population: cross-sectional study of cardiovascular disease and risk factors Br Med J 1998; 317: 1125-30.
34. 34 Troein M, Gardell B, Selander S, Råstam L. Guidelines and reported practice for the treatment of hypertension and hypercholesterolemia. J Intern Med 1997; 242: 173-8.
35. 55 Durrington PN. Can we afford to treat hyperlipidemia as we should? Strategies for rational treatment. Atherosclerosis 1998; 139 (Suppl. 1): 1S-5S.